Phase 2 Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab.
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs Lenalidomide; Ofatumumab
- Indications Chronic lymphocytic leukaemia
- Focus Biomarker; Therapeutic Use
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 May 2010 New trial record